Robotic versus laparoscopic liver resection for huge (≥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases.
Laparoscopic liver resection (LLR)
colorectal liver metastases
hepatocellular carcinoma
huge
robotic liver resection (RLR)
Journal
Hepatobiliary surgery and nutrition
ISSN: 2304-3881
Titre abrégé: Hepatobiliary Surg Nutr
Pays: China (Republic : 1949- )
ID NLM: 101600750
Informations de publication
Date de publication:
10 Apr 2023
10 Apr 2023
Historique:
received:
09
07
2022
accepted:
15
10
2022
medline:
1
5
2023
pubmed:
1
5
2023
entrez:
1
5
2023
Statut:
ppublish
Résumé
The use of laparoscopic (LLR) and robotic liver resections (RLR) has been safely performed in many institutions for liver tumours. A large scale international multicenter study would provide stronger evidence and insight into application of these techniques for huge liver tumours ≥10 cm. This was a retrospective review of 971 patients who underwent LLR and RLR for huge (≥10 cm) tumors at 42 international centers between 2002-2020. One hundred RLR and 699 LLR which met study criteria were included. The comparison between the 2 approaches for patients with huge tumors were performed using 1:3 propensity-score matching (PSM) (73 RLR and LLR can be performed safely for selected patients with huge liver tumours with excellent outcomes. There was no significant difference in perioperative outcomes after RLR or LLR.
Sections du résumé
Background
UNASSIGNED
The use of laparoscopic (LLR) and robotic liver resections (RLR) has been safely performed in many institutions for liver tumours. A large scale international multicenter study would provide stronger evidence and insight into application of these techniques for huge liver tumours ≥10 cm.
Methods
UNASSIGNED
This was a retrospective review of 971 patients who underwent LLR and RLR for huge (≥10 cm) tumors at 42 international centers between 2002-2020.
Results
UNASSIGNED
One hundred RLR and 699 LLR which met study criteria were included. The comparison between the 2 approaches for patients with huge tumors were performed using 1:3 propensity-score matching (PSM) (73
Conclusions
UNASSIGNED
RLR and LLR can be performed safely for selected patients with huge liver tumours with excellent outcomes. There was no significant difference in perioperative outcomes after RLR or LLR.
Identifiants
pubmed: 37124684
doi: 10.21037/hbsn-22-283
pii: hbsn-12-02-205
pmc: PMC10129897
doi:
Types de publication
Journal Article
Langues
eng
Pagination
205-215Investigateurs
Chung-Yip Chan
(CY)
Mizelle D'Silva
(M)
Henri Schotte
(H)
Celine De Meyere
(C)
Eric C H Lai
(ECH)
Felix Krenzien
(F)
Moritz Schmelzle
(M)
Prashant Kadam
(P)
Roberto Montalti
(R)
Mariano Giglio
(M)
Qu Liu
(Q)
Kit-Fai Lee
(KF)
Diana Salimgereeva
(D)
Ruslan Alikhanov
(R)
Lip-Seng Lee
(LS)
Mikel Prieto
(M)
Jae Young Jang
(JY)
Victor Lopez-Lopez
(V)
Paolo Magistri
(P)
Margarida Casellas I Robert
(MCI)
Chetana Lim
(C)
Kevin P Labadie
(KP)
Phan Phuoc Nghia
(PP)
Masayuki Kojima
(M)
Yutaro Kato
(Y)
Kohei Mishima
(K)
Mansour Saleh
(M)
Franco Pascual
(F)
Fabricio Ferreira Coelho
(FF)
Jaime Arthur Pirola Kruger
(JAP)
Astmund Avdem Fretland
(AA)
Jacob Ghotbi
(J)
Bernardo Dalla Valle
(BD)
Amal Suhool
(A)
Ugo Giustizieri
(U)
Davide Citterio
(D)
Simone Vani
(S)
Tiing Foong Siow
(TF)
Fabio Forchino
(F)
Informations de copyright
2023 Hepatobiliary Surgery and Nutrition. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-22-283/coif). FR reports speaker fees and support outside the submitted work from Integra, Medtronic, Olympus, Corza, Sirtex and Johnson & Johnson. MVM is a consultant for CAVA robotics LLC. JP reports a research grant from Intuitive Surgical Deutschland GmbH and personal fees or nonfinancial support from Johnson & Johnson, Medtronic, AFS Medical, Astellas, CHG Meridian, Chiesi, Falk Foundation, La Fource Group, Merck, Neovii, NOGGO, pharma-consult Peterson, and Promedicis and serves as the unpaid editorial board member of Hepatobiliary Surgery and Nutrition. BKPG has received travel grants and honorarium from Johnson and Johnson, Olympus and Transmedic the local distributor for the Da Vinci Robot. HSH, MAH and LA serve as the unpaid editorial board members of Hepatobiliary Surgery and Nutrition. The other authors have no conflicts of interest to declare.
Références
J Robot Surg. 2023 Feb;17(1):79-88
pubmed: 35322342
World J Hepatol. 2022 Jan 27;14(1):224-233
pubmed: 35126850
Hepatobiliary Surg Nutr. 2021 Oct;10(5):587-597
pubmed: 34760963
Br J Surg. 2021 Apr 30;108(4):351-358
pubmed: 33779690
Aust N Z J Surg. 1972 Aug;42(1):1-10
pubmed: 4267012
Surg Endosc. 2021 Feb;35(2):524-535
pubmed: 32989544
Surg Endosc. 2008 Feb;22(2):372-8
pubmed: 17704878
Surg Oncol. 2020 Dec;35:315-320
pubmed: 32977103
Ann Surg. 2018 Jan;267(1):13-17
pubmed: 28187043
J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):732-6
pubmed: 25098667
Surg Oncol. 2021 Jun;37:101569
pubmed: 33839442
Ann Acad Med Singap. 2020 Oct;49(10):742-748
pubmed: 33283837
J Surg Oncol. 2017 Mar;115(3):324-329
pubmed: 28192617
ANZ J Surg. 2020 Apr;90(4):553-557
pubmed: 31721400
Eur J Surg Oncol. 2022 Jan;48(1):169-176
pubmed: 34420824
Ann Surg. 2008 Sep;248(3):475-86
pubmed: 18791368
Br J Surg. 2022 Mar 15;109(4):311-314
pubmed: 35139157
Br J Surg. 2021 Dec 1;108(12):1513-1520
pubmed: 34750608
ANZ J Surg. 2020 Jun;90(6):1092-1098
pubmed: 31957149
HPB (Oxford). 2002;4(2):99; author reply 99-100
pubmed: 18332933
Surg Endosc. 2021 May;35(5):2316-2323
pubmed: 33185767
Hepatobiliary Surg Nutr. 2016 Aug;5(4):281-9
pubmed: 27500140
Ann Acad Med Singap. 2021 Oct;50(10):742-750
pubmed: 34755168
Ann Surg. 2021 Dec 1;274(6):1043-1050
pubmed: 32209896
Ann Surg Oncol. 2015 Apr;22(4):1288-93
pubmed: 25256130
Surg Endosc. 2021 Sep;35(9):5268-5278
pubmed: 33174100
Ann Surg. 2021 Jan 1;273(1):96-108
pubmed: 33332874
ANZ J Surg. 2019 Mar;89(3):201-205
pubmed: 29512261
Ann Surg. 2009 Jul;250(1):103-11
pubmed: 19561476
Ann Surg. 2013 Mar;257(3):506-11
pubmed: 23299521
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Surg Endosc. 2018 Nov;32(11):4658-4665
pubmed: 29967997
JAMA Surg. 2022 May 1;157(5):436-444
pubmed: 35262660
Ann Surg. 2019 Feb;269(2):221-228
pubmed: 30080729
Ann Hepatobiliary Pancreat Surg. 2021 Feb 28;25(1):8-17
pubmed: 33649249